Singlera Genomics, a non-invasive genetic diagnostics company that focuses on early-stage cancer detection, has secured a $60 million Series A+ financing.
Oncology is the most advanced area in genomics right now. The field is setting the standard for other indications to follow and improve upon.
Combining a cancer therapy with a second drug therapy that helps suppress tumour blood vessels found in cancer cells can help to significantly reduce the spread of breast cancer tumours while also causing cancer cell death.
The human body was thought to have 79 organs—until researchers stumbled on a strange phenomenon that could turn medicine and what we thought we knew about the body upside down.
DNA has an important job—it tells your cells which proteins to make. Now, a research team at the University of Delaware has developed technology to program strands of DNA into switches that turn proteins on and off.
A new study by Cancer Research UK has found that more than 135,500 cases of cancer every year in the UK could be prevented through lifestyle changes.
Researchers have developed a test that provides a safe and minimally invasive method for earlier diagnosis of ovarian and endometrial cancers.
Being obese or having a higher BMI while carrying a BRCA mutation is positively linked with higher levels of damage to the DNA in normal breast gland cells, new research suggests.